(Precision Vaccinations News)
A clinical trial due to launch in the Democratic Republic of Congo (DRC) and other African countries will assess whether a mpox vaccine can protect people against the disease after they have come into contact with the virus.
As of July 29, 2024, the phase 4…
[ad_2]
Source link
